10 April 2025 Decision overturns earlier decision allowing generic drug maker to launch version | Dispute centres on ...

Firm’s chair says Fenwick has been active in market for a long time and “waiting to find the right opportunity to deepen our bench and presence”.

Prompter patent issue will provide earlier protection for inventions and could avoid need for Quick Path Information ...

Massachusetts lawsuit claims subsidiary of UK pharma company unlawfully re-patented eculizumab, resulting in overpayments of ...

New partner brings 16 years of experience in biotechnology and pharmaceutical patent prosecution to Chicago | Regularly advises on animal biotechnology, antibodies and biologics, cell biology, ...

Texas company launches sweeping lawsuits against five major players, alleging infringement of medical device patents tied to ...

Court hears arguments from J&J and Teva to determine whether a patent blocking generic versions of Invega Sustenna will be upheld | J&J fights to protect its last remaining Orange Book patent covering ...

A new High Court judge will be tasked with the “massive decision” of deciding on the plausibility of a key anticoagulant patent belonging to BMS, following the pharma company’s appeal over failures in ...

AstraZeneca fends off diabetes generic, for now ...

The Düsseldorf court’s decision offers an instructive perspective on the legal nature of patent pledges as well as a reminder ...